Close Menu

NEW YORK (GenomeWeb) – NanoString said today that life science reagents firm Abcam will provide antibodies for use with its GeoMx Digital Spatial Profiler (DSP) platform, which the company launched this week at the American Association for Cancer Research annual meeting.

Under the agreement, Abcam will create custom panels for the GeoMx DSP platform from its collection of 6,000-plus recombinant monoclonal antibodies, which have been validated for use in fresh frozen and formalin-fixed paraffin-embedded tissue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.